We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Biogen Accused Of Stifling Neurological Drug Competition

Law360, Los Angeles (April 4, 2017, 7:05 PM EDT) -- Biogen Inc. is facing an antitrust suit in California federal court filed Tuesday by Ixchel Pharma LLC alleging it attempted to hold a monopoly on drug treatments containing dimethyl fumarate, preventing...
To view the full article, register now.




Case Information

Case Title

Subscribers Only

Case Number

Subscribers Only


California Eastern

Nature of Suit



Subscribers Only

Date Filed

April 4, 2017

Law Firms


Government Agencies

Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.